Newsroom
Stock News: GeneDx (WGS) Investors Face Securities Class Action Lawsuit Deadline
By KlickAnalytics Data Insights | June 30, 2026 08:03PM ET
Key Points
- Faruqi & Faruqi, LLP reminds GeneDx (WGS) investors of the August 3, 2026, deadline for a securities class action lawsuit.
- Hagens Berman investigates claims against GeneDx Holdings (WGS) following a 49% stock collapse.
- Robbins Geller Rudman & Dowd LLP announces an opportunity for investors with substantial losses to lead the class action lawsuit against GeneDx.
- Pomerantz Law Firm reminds investors with losses in GeneDx Holdings Corp. of the upcoming deadlines for the class action lawsuit.
- GeneDx Holdings faces lawsuits from various law firms due to alleged securities fraud and misrepresentations.
Investors who suffered losses in GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025, and May 4, 2026, are urged to take action before the August 3, 2026, deadline in a securities class action lawsuit. Faruqi & Faruqi, LLP, a national securities law firm, is actively investigating potential claims against GeneDx and reminds investors of the looming deadline to seek the role of lead plaintiff in the federal securities class action.
Following a massive impairment charge and a 49% stock collapse on May 5, 2026, Hagens Berman (HBSS), a prominent securities litigation leader, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings and its executives. The lawsuit alleges that the defendants misled investors about the Fabric Genomics acquisition and synergy potential, leading to substantial losses.
Robbins Geller Rudman & Dowd LLP has announced that investors with significant losses have an opportunity to lead the class action lawsuit against GeneDx Holdings. Purchasers of GeneDx common stock between April 16, 2025, and May 4, 2026, have until August 3, 2026, to seek appointment as a lead plaintiff in the GeneDx class action lawsuit.
Pomerantz Law Firm, another legal entity, has filed a class action lawsuit against GeneDx Holdings Corp., advising investors with losses on their investment to take action before the upcoming deadlines. Investors who purchased or acquired GeneDx securities between April 16, 2025, and May 4, 2026, are encouraged to contact the firm to discuss their legal rights and potential compensation.
Various law firms, including Kahn Swick & Foti, LLC and Rosen Law Firm, are also urging GeneDx Holdings Corp. investors to take action before the important deadline in a securities class action lawsuit. Investors with substantial losses are reminded to file lead plaintiff applications if they purchased or acquired the company's shares between April 16, 2025, and May 4, 2026, the period in question for the class action lawsuit.
In the midst of increasing legal scrutiny and investor allegations of securities fraud and misrepresentations, GeneDx Holdings Corp. continues to face mounting pressure from multiple law firms. Investors are advised to stay informed and consider their legal options before the deadline to seek potential compensation.
For more information:
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with